Evidence map›Paper›PMID 34458934›Full record

ArticleDiabetologia2021

Consensus report: definition and interpretation of remission in type 2 diabetes.

Matthew C Riddle, William T Cefalu, Philip H Evans, Hertzel C Gerstein, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip Schauer and 2 more

Abstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in Diabetologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023
    Review
  14. Review
  15. Article
  16. [Lifetide biofeedback intervention in type 2 diabetic patients: a pilot observation].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Matthew C RiddleDivision of Endocrinology, Diabetes, & Clinical Nutrition, Department of Medicine, Oregon Health & Science University, Portland, OR, USA. riddlem@ohsu.edu.ORCID 0000-0003-1169-3036
William T CefaluDivision of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-9979-6445
Philip H EvansCollege of Medicine and Health, University of Exeter, Exeter, UK.ORCID 0000-0002-5277-3545
Hertzel C GersteinPopulation Health Research Institute and Department of Medicine, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.ORCID 0000-0001-8072-2836
Michael A NauckDiabetes Division, Katholisches Klinikum Bochum gGmbH, St Josef-Hospital, Ruhr University Bochum, Bochum, Germany.ORCID 0000-0002-5749-6954
William K OhDivision of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-5113-8147
Amy E RothbergDepartment of Internal Medicine, Michigan Medicine, and Department of Nutritional Sciences, School of Public Health, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-0243-9135
Carel W le RouxDiabetes Complications Research Centre, University College Dublin, Dublin, Ireland.ORCID 0000-0001-5521-5445
Francesco RubinoDepartment of Diabetes, School of Life Course Sciences, King's College London, London, UK.ORCID 0000-0001-8581-2515
Philip SchauerPennington Biomedical Research Center, Baton Rouge, LA, USA.ORCID 0000-0001-6258-5604
Roy TaylorTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0001-6273-0170
Douglas TwenefourDiabetes UK, London, UK.ORCID 0000-0003-1282-6814

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improvement of glucose levels into the normal range can occur in some people living with diabetes, either spontaneously or after medical interventions, and in some cases can persist after withdrawal of glucose-lowering pharmacotherapy. Such sustained improvement may now be occurring more often due to newer forms of treatment. However, terminology for describing this process and objective measures for defining it are not well established, and the long-term risks vs benefits of its attainment are not well understood. To update prior discussions of this issue, an international expert group was convened by the American Diabetes Association to propose nomenclature and principles for data collection and analysis, with the goal of establishing a base of information to support future clinical guidance. This group proposed 'remission' as the most appropriate descriptive term, and HbA

Indexed as

Blood GlucoseData Interpretation, StatisticalDiabetes Mellitus, Type 2Glycated HemoglobinHumansHypoglycemic AgentsRemission InductionRemission, SpontaneousTerminology as TopicBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic Agents

Identifiers

PMID34458934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.